Phase IIIb Multaq study halted due to CV events

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1360, 2011-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy trials halted due to leukaemia-like disorder

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The US FDA and Health Canada have both announced that they are reviewing the cardiovascular (CV) safety of dronedarone [Multaq]

By  

Reactions Weekly, Vol. 1, Iss. 1362, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Serious adverse CV events with varenicline

By  

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

CV events with proton pump inhibitors and clopidogrel

By  

Reactions Weekly, Vol. 1, Iss. 1229, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Evidence of CV events with calcium/vitamin D not convincing

By  

Reactions Weekly, Vol. 1, Iss. 1374, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite